MeSH term
Frequency | Condition_Probility | Adenosine Diphosphate/metabolism | 2 | 3.0 |
Adenosine Triphosphate/metabolism | 7 | 1.0 |
Carrier Proteins/genetics/*metabolism | 10 | 2.0 |
*Energy Metabolism | 6 | 6.0 |
Humans | 156 | 0.0 |
*Membrane Transport Proteins | 109 | 18.0 |
*Mitochondrial Proteins | 106 | 61.0 |
Muscle, Skeletal/*physiology | 3 | 3.0 |
Proteins/genetics/*metabolism | 12 | 2.0 |
Research Support, Non-U.S. Gov't | 106 | 0.0 |
Uncoupling Agents/metabolism | 10 | 83.0 |
Adipocytes/*metabolism | 2 | 4.0 |
Animals | 82 | 0.0 |
Carrier Proteins/genetics | 5 | 1.0 |
Energy Metabolism | 17 | 9.0 |
Lipids/*metabolism | 4 | 1.0 |
Membrane Proteins/genetics | 4 | 1.0 |
Mice | 34 | 0.0 |
Signal Transduction | 3 | 0.0 |
Membrane Proteins/*physiology | 5 | 3.0 |
Models, Biological | 13 | 0.0 |
Obesity/metabolism | 2 | 4.0 |
Proteins/physiology | 3 | 2.0 |
Adult | 43 | 0.0 |
Aged | 15 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Apoptosis | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
Female | 54 | 0.0 |
Immunoblotting | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Intracellular Membranes/metabolism | 4 | 2.0 |
Male | 63 | 0.0 |
Middle Aged | 32 | 0.0 |
Oligonucleotide Array Sequence Analysis | 4 | 0.0 |
RNA, Messenger/metabolism | 13 | 0.0 |
Reactive Oxygen Species/metabolism | 7 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 14 | 0.0 |
Up-Regulation | 7 | 0.0 |
Adipose Tissue/*metabolism | 6 | 5.0 |
Cell Line | 6 | 0.0 |
Comparative Study | 12 | 0.0 |
*Gene Expression Regulation | 6 | 0.0 |
Protein Isoforms/genetics | 2 | 0.0 |
RNA, Messenger/genetics | 4 | 0.0 |
Transcription, Genetic | 5 | 0.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
RNA, Messenger/analysis | 12 | 0.0 |
Carrier Proteins/*physiology | 5 | 2.0 |
Muscle, Skeletal/chemistry | 3 | 15.0 |
Nerve Tissue Proteins/physiology | 2 | 4.0 |
Obesity | 4 | 6.0 |
Tissue Distribution | 6 | 0.0 |
*Uncoupling Agents | 4 | 66.0 |
Body Mass Index | 15 | 1.0 |
Calorimetry, Indirect | 4 | 7.0 |
Carrier Proteins/*genetics | 22 | 1.0 |
Densitometry, X-Ray | 2 | 1.0 |
Genotype | 19 | 0.0 |
Membrane Proteins/*genetics | 4 | 0.0 |
Obesity/*genetics | 15 | 12.0 |
Proteins/*genetics | 34 | 2.0 |
Citrate (si)-Synthase/metabolism | 2 | 3.0 |
Gene Expression Regulation | 14 | 0.0 |
Kinetics | 6 | 0.0 |
Muscle, Skeletal/*metabolism | 16 | 9.0 |
Proteins/genetics/metabolism | 3 | 1.0 |
Carrier Proteins/*metabolism | 10 | 1.0 |
Fatty Acids/metabolism | 6 | 4.0 |
Membrane Proteins/*metabolism | 8 | 1.0 |
Mitochondria/metabolism | 15 | 5.0 |
Proteins/metabolism | 7 | 0.0 |
Adipose Tissue/metabolism | 13 | 10.0 |
Carrier Proteins/*metabolism/*physiology | 2 | 13.0 |
Mice, Knockout | 6 | 0.0 |
Mice, Obese | 4 | 9.0 |
Fatty Acids/*metabolism | 2 | 2.0 |
Insulin Resistance | 3 | 1.0 |
Lipids/metabolism | 2 | 0.0 |
Muscle, Skeletal/metabolism | 8 | 4.0 |
Body Weight | 6 | 0.0 |
Linkage (Genetics) | 4 | 0.0 |
Membrane Proteins/genetics/physiology | 2 | 8.0 |
Basal Metabolism | 5 | 11.0 |
Energy Intake | 4 | 2.0 |
Energy Metabolism/*genetics | 5 | 33.0 |
Obesity/etiology/*genetics | 2 | 66.0 |
Polymerase Chain Reaction | 10 | 0.0 |
Polymorphism, Restriction Fragment Length | 3 | 0.0 |
Proteins/genetics | 9 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 29 | 0.0 |
Uncoupling Agents | 5 | 62.0 |
Variation (Genetics) | 3 | 0.0 |
Body Composition/physiology | 2 | 3.0 |
Fatty Acids, Nonesterified/metabolism | 2 | 6.0 |
Obesity/*metabolism | 4 | 5.0 |
Thermogenesis/*physiology | 3 | 42.0 |
Carrier Proteins/*genetics/physiology | 2 | 5.0 |
Diabetes Mellitus, Type 2/*genetics | 3 | 1.0 |
Gene Expression | 9 | 0.0 |
Mutation | 4 | 0.0 |
Proteins/*genetics/physiology | 2 | 2.0 |
Amino Acid Sequence | 23 | 0.0 |
Base Sequence | 16 | 0.0 |
Blotting, Northern | 6 | 0.0 |
Cloning, Molecular | 16 | 0.0 |
Conserved Sequence | 2 | 0.0 |
DNA, Complementary/metabolism | 3 | 0.0 |
In Situ Nick-End Labeling | 2 | 0.0 |
Liver/*metabolism | 2 | 0.0 |
Membrane Potentials | 6 | 2.0 |
Models, Genetic | 2 | 0.0 |
Molecular Sequence Data | 28 | 0.0 |
Protons | 8 | 8.0 |
Rats | 19 | 0.0 |
Sequence Homology, Amino Acid | 16 | 0.0 |
Transfection | 6 | 0.0 |
Body Weight/*genetics | 2 | 13.0 |
*Polymorphism, Genetic | 6 | 0.0 |
Blood Glucose/metabolism | 9 | 1.0 |
Diabetes Mellitus/*metabolism | 2 | 5.0 |
Diabetes Mellitus, Type 2/*metabolism | 2 | 4.0 |
Homeostasis | 3 | 0.0 |
Insulin/blood/metabolism/*secretion | 2 | 50.0 |
Islets of Langerhans/*metabolism/secretion | 2 | 66.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Thermogenesis | 5 | 55.0 |
Glucose/metabolism | 3 | 1.0 |
Mice, Transgenic | 4 | 0.0 |
Brown Fat/physiology | 3 | 60.0 |
Energy Metabolism/*physiology | 6 | 6.0 |
Mitochondria/*metabolism | 18 | 11.0 |
Obesity/*physiopathology | 2 | 3.0 |
Thermogenesis/physiology | 2 | 33.0 |
Uncoupling Agents/*metabolism | 10 | 58.0 |
3' Untranslated Regions | 2 | 1.0 |
Binding Sites | 5 | 0.0 |
Case-Control Studies | 9 | 0.0 |
Cross-Sectional Studies | 2 | 0.0 |
Gene Frequency | 8 | 0.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Energy Metabolism/physiology | 7 | 11.0 |
Homeostasis/physiology | 2 | 3.0 |
Proteins/*metabolism | 9 | 1.0 |
Membrane Transport Proteins/*physiology | 2 | 66.0 |
Mitochondrial Proteins/*physiology | 3 | 42.0 |
Oxygen/metabolism | 2 | 0.0 |
Alanine | 3 | 3.0 |
Homozygote | 4 | 0.0 |
Linkage Disequilibrium | 2 | 0.0 |
Oxygen Consumption | 6 | 2.0 |
Valine | 2 | 3.0 |
Age Factors | 3 | 0.0 |
Physical Endurance/physiology | 2 | 6.0 |
Sex Factors | 2 | 0.0 |
Mitochondria/physiology | 2 | 3.0 |
Phylogeny | 2 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
Child | 7 | 0.0 |
Body Composition | 6 | 2.0 |
Thyroxine/blood | 2 | 0.0 |
Animals, Genetically Modified | 2 | 0.0 |
*Protons | 2 | 11.0 |
Sequence Alignment | 5 | 0.0 |
Sequence Homology | 3 | 0.0 |
Brown Fat/*metabolism | 8 | 53.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Fatty Acids/chemistry/metabolism | 2 | 22.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Membrane Proteins/genetics/*metabolism | 4 | 1.0 |
Models, Chemical | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Proteolipids/metabolism | 2 | 8.0 |
Basal Metabolism/genetics | 2 | 66.0 |
Gene Expression Regulation/drug effects | 5 | 0.0 |
Models, Molecular | 2 | 0.0 |
Plants | 2 | 15.0 |
Proteins/chemistry/metabolism | 2 | 6.0 |
Retinoids/pharmacology | 2 | 9.0 |
Uncoupling Agents/chemistry/*metabolism | 2 | 66.0 |
Brown Fat/metabolism | 8 | 42.0 |
Carrier Proteins/genetics/*physiology | 5 | 5.0 |
Cells, Cultured | 7 | 0.0 |
Membrane Proteins/genetics/*physiology | 2 | 3.0 |
Proteins/genetics/*physiology | 3 | 2.0 |
Down-Regulation | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Fatty Acids/pharmacology | 2 | 11.0 |
Liposomes/metabolism | 3 | 5.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Purine Nucleotides/pharmacology | 2 | 50.0 |
Structure-Activity Relationship | 4 | 0.0 |
Dose-Response Relationship, Drug | 3 | 0.0 |
Hamsters | 3 | 0.0 |
Antibody Specificity | 2 | 0.0 |
Biopsy | 2 | 0.0 |
Muscle, Skeletal/chemistry/*metabolism | 2 | 40.0 |
*Weight Loss | 2 | 4.0 |
DNA Primers | 13 | 0.0 |
Exons | 7 | 0.0 |
Open Reading Frames | 2 | 0.0 |
*Protein Biosynthesis | 7 | 1.0 |
Mitochondria/drug effects/metabolism | 2 | 6.0 |
Carrier Proteins/chemistry/*genetics | 2 | 3.0 |
Nerve Tissue Proteins/chemistry/*genetics | 2 | 4.0 |
*Exercise | 3 | 2.0 |
Mitochondria, Muscle/*metabolism | 2 | 16.0 |
Body Composition/drug effects | 2 | 14.0 |
*Diet, Reducing | 2 | 2.0 |
Regression Analysis | 3 | 0.0 |
Asian Continental Ancestry Group/genetics | 2 | 0.0 |
Body Constitution | 3 | 2.0 |
European Continental Ancestry Group/genetics | 3 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Saccharomyces cerevisiae/genetics | 4 | 0.0 |
Animals, Newborn | 4 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Protein Folding | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
RNA, Messenger/drug effects/genetics/metabolism | 2 | 2.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Swine | 2 | 0.0 |
DNA Transposable Elements | 2 | 1.0 |
Heterozygote | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 4 | 0.0 |
*Body Mass Index | 2 | 2.0 |
Denmark | 3 | 1.0 |
Obesity/genetics | 2 | 3.0 |
Amino Acid Substitution | 2 | 0.0 |
Indians, North American/*genetics | 2 | 2.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 3 | 0.0 |
Obesity/genetics/metabolism | 2 | 14.0 |
*Chromosome Mapping | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Adolescent | 8 | 0.0 |
Glucose Clamp Technique | 3 | 2.0 |
Insulin Resistance/*genetics | 2 | 2.0 |
Membrane Transport Proteins/*genetics | 11 | 18.0 |
Mitochondrial Proteins/*genetics | 11 | 57.0 |
Obesity/genetics/physiopathology | 4 | 50.0 |
Gene Expression Regulation/*drug effects | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
DNA Primers/genetics | 4 | 0.0 |
Oxidation-Reduction | 3 | 0.0 |
Proteins/chemistry/*genetics | 2 | 1.0 |
Carrier Proteins/*biosynthesis/genetics | 4 | 7.0 |
Lauric Acids/pharmacology | 2 | 28.0 |
Spectrometry, Fluorescence | 2 | 0.0 |
Cell Respiration | 2 | 40.0 |
Weight Loss | 2 | 1.0 |
Mitochondria/*physiology | 4 | 7.0 |
Body Temperature Regulation/physiology | 2 | 8.0 |
Yeasts | 2 | 2.0 |
Carrier Proteins/metabolism | 4 | 0.0 |
Catalysis | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Muscle, Skeletal | 2 | 10.0 |
Oxidative Phosphorylation | 5 | 14.0 |
Proteins/immunology/*metabolism | 2 | 11.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Genetic Predisposition to Disease | 3 | 0.0 |
Risk Factors | 4 | 0.0 |
English Abstract | 3 | 0.0 |
*Mutation | 5 | 0.0 |
Amino Acid Substitution/genetics | 2 | 0.0 |
Japan | 2 | 0.0 |
Thiazoles/*pharmacology | 3 | 5.0 |
*Thiazolidinediones | 3 | 3.0 |
Triglycerides/metabolism | 2 | 1.0 |
Leptin | 5 | 4.0 |
*Gene Expression | 3 | 0.0 |
Mitochondria/chemistry | 2 | 20.0 |
Rats, Inbred Strains | 2 | 0.0 |
Chromosomes, Human, Pair 11/genetics | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Introns | 3 | 0.0 |
Polymorphism, Genetic | 5 | 0.0 |
Adipocytes/*drug effects/metabolism | 2 | 33.0 |
Adipose Tissue | 2 | 3.0 |
Time Factors | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Mice, Inbred Strains | 2 | 0.0 |
Introns/genetics | 2 | 0.0 |
Phenotype | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Intracellular Membranes/physiology | 3 | 10.0 |
Organ Specificity | 2 | 0.0 |
Obesity/epidemiology/*genetics | 2 | 18.0 |
*Polymorphism, Single Nucleotide | 4 | 0.0 |
Obesity, Morbid/*metabolism/surgery | 2 | 66.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Alleles | 5 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Linear Models | 2 | 0.0 |
Proteins/genetics/*pharmacology | 2 | 25.0 |
Adenoviridae/genetics | 2 | 0.0 |
Chromosomes, Human, Pair 11 | 3 | 0.0 |
RNA, Messenger | 2 | 0.0 |
Obesity/genetics/*metabolism | 3 | 60.0 |
Insulin/blood | 6 | 0.0 |
Insulin Resistance/genetics | 2 | 5.0 |
*Cold | 2 | 3.0 |
Biological Markers/blood | 2 | 0.0 |
Diabetes Mellitus/genetics | 2 | 5.0 |
Statistics | 2 | 0.0 |
Obesity/*genetics/metabolism | 2 | 14.0 |
Multivariate Analysis | 2 | 0.0 |
Prospective Studies | 2 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Cholesterol/blood | 2 | 0.0 |
Cohort Studies | 2 | 0.0 |
Polymorphism, Single Nucleotide/*genetics | 2 | 0.0 |
Gestational Age | 2 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Adenosine Triphosphate/*metabolism/pharmacology | 2 | 22.0 |
Plasmids/metabolism | 2 | 0.0 |
Protein Transport | 2 | 0.0 |
Fatty Acids, Omega-6 | 2 | 15.0 |
Odds Ratio | 2 | 0.0 |
